ELN-21

N/A

Report date: 2025/01/26 19:12:15

Base Information

Drug NameELN-21
Drug Alias Nameanti-ICOSL soloMERs (Elasmogen)ELN-21
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionICOS ligand inhibitors
TargetsICOS ligand
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElasmogen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesElasmogen Ltd
Inactive CompaniesN/A
Active IndicationsUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A